Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page
- Check5 days agoChange DetectedRevision tag on the page was updated from v3.6.0 to v3.6.2, indicating a platform revision. The change is purely technical and does not affect the study details displayed on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was standardized. The page's revision metadata was updated to Revision: v3.6.0, and additional fields such as 'Last verified' and 'Last known status was' appeared.SummaryDifference1%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page’s documentation/versioning. It does not modify the study details or other critical content.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page footer now shows a newer revision label (v3.5.4), indicating a minor build update. This change does not modify the study details or other user-facing content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page’s footer revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a change in the site build rather than any study details.SummaryDifference0.1%

- Check77 days agoChange DetectedA new release version v3.5.2 was added and the previous v3.5.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.